⌘K

Login Start Free

Home/Filings/4/0001144204-18-050781

4//SEC Filing

BHONSLE SUNIL 4

Accession 0001144204-18-050781

CIK 0000910267other

View on SEC.gov Company Profile

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 7:06 PM ET

Size

7.6 KB

Accession

0001144204-18-050781

Insider Transaction Report

Form 4

Period: 2018-09-21

TITAN PHARMACEUTICALS INCTTP

DirectorPresident

Transactions

Purchase
Common Stock
2018-09-21$0.25/sh+300,000$75,000→ 435,578 total
Award
Warrants
2018-09-21+300,000→ 300,000 total
Exercise: $0.25From: 2023-09-25Exp: 2023-09-25→ common stock (300,000 underlying)

Holdings

Common Stock
(indirect: By Trust)
54,684

Footnotes (1)

[F1]The reporting person serves as trustee of the family trust.

Documents

1 file

4
tv503427_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother

Related Parties

1

filerCIK 0001180755

Filing Metadata

Form type: 4
Filed: Sep 24, 8:00 PM ET
Accepted: Sep 25, 7:06 PM ET
Size: 7.6 KB

View on SEC.gov